---
title: Carbogen Amcis vs Quotient Sciences
slug_a: carbogen-amcis
slug_b: quotientsciences
site: cdmo
review_signal_gate: closed
canonical_path: /compare/carbogen-amcis/quotientsciences
---

# Carbogen Amcis vs Quotient Sciences

Side-by-side profile data from each company listing on this directory.

## Carbogen Amcis

- Profile: [/companies/carbogen-amcis](/companies/carbogen-amcis)

Carbogen Amcis — Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.

Services: 18. Modalities: 2. Indications: 0. Locations: 14. Certifications: 5. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Flow Chemistry
- Hydrogenation
- Cryogenic (−80 °C)

## Quotient Sciences

- Profile: [/companies/quotientsciences](/companies/quotientsciences)

Quotient Sciences — Integrated CDMO offering drug product formulation and manufacturing for small molecules and synthetic peptides, with 30+ years of experience and scalable capacity from clinical to 500 kg commercial batches across US and UK facilities.

Services: 13. Modalities: 2. Indications: 0. Locations: 12. Certifications: 4. The strongest documented coverage currently appears in services (13).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Peptide Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Oral Solid Dosage Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI